Hermetica Superfood Encyclopedia
The Short Answer
Litsea cubeba essential oil (LCEO) is dominated by citral monoterpenes—specifically neral and geranial, comprising up to 75–80% of fruit oil—which disrupt microbial cell membranes and scavenge free radicals via their reactive aldehyde functional groups. In vitro assays demonstrate antibacterial activity against Staphylococcus aureus at a minimum inhibitory concentration (MIC) of 5.24 μg/mL for high-citral fractions, and antifungal efficacy against Fusarium verticillioides at MIC/MFC of 125 μg/mL with dose-dependent suppression of fumonisin B1/B2 mycotoxin synthesis (p < 0.01).
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordlitsea cubeba benefits
Litsea cubeba — botanical close-up
Health Benefits
**Antibacterial Activity**
Citral components (neral and geranial) in LCEO disrupt bacterial cell membrane integrity, achieving MIC values as low as 5.24 μg/mL against Staphylococcus aureus; verbenol present in the oil contributes additional activity against Gram-negative Escherichia coli.
**Antifungal and Antimycotoxigenic Effects**
LCEO at 125 μg/mL (MIC/MFC) morphologically damages Fusarium verticillioides hyphae and microconidia, simultaneously reducing fumonisin B1 and B2 mycotoxin biosynthesis in a dose-dependent manner (p < 0.01), suggesting dual utility as a food preservative and antifungal agent.
**Antioxidant Free Radical Scavenging**
LCEO fractions exhibit DPPH radical scavenging activity with IC50 values ranging from 872 to 1720.1 μg/mL; Trolox equivalent antioxidant capacity reaches 104.4 mmol/mg (DPPH assay) and 56.4 mmol/mg (ABTS assay), with limonene content positively correlating with scavenging potency.
**Digestive System Support in Traditional Medicine**
In Indonesian Jamu and Chinese folk medicine, Litsea cubeba fruits are used to address digestive disorders including bloating, colic, and dyspepsia, attributed to the carminative properties of its volatile monoterpenes; however, mechanistic clinical evidence in humans remains absent.
**Potential Cytotoxic Effects Against Cancer Cell Lines**
LCEO inhibits proliferation of HT-29 colorectal adenocarcinoma and HeLa cervical carcinoma cells in vitro, a finding attributed to terpene-mediated membrane disruption and induction of oxidative stress, though no in vivo oncology studies have been conducted.
**Food Preservation and Antimicrobial Application**
The high citral content of LCEO provides functional utility as a natural preservative against foodborne pathogens and spoilage fungi, with in vitro evidence supporting effective concentrations around 2.00 mg/mL for antibacterial applications.
**Aromatic and Psychophysiological Use**
The lemon-like fragrance from citral, limonene, and linalool in LCEO is used in aromatherapy and cosmetic formulations; linalool (up to 9.5% in leaf oil) is associated with anxiolytic-adjacent aromatic properties studied in related essential oil research, though direct clinical data for Litsea cubeba specifically is lacking.
Origin & History
Natural habitat
Litsea cubeba is native to subtropical and tropical regions of East and Southeast Asia, including China, Indonesia, Taiwan, Japan, and Vietnam, where it grows in mountainous forests at elevations between 500 and 3,400 meters. The small deciduous tree or shrub produces pepper-like fruits roughly 5–6 mm in diameter that are the primary source of its commercially valued essential oil. Cultivation is most concentrated in southern China's Hunan, Fujian, and Guangdong provinces, as well as across the Indonesian archipelago, where the plant is integral to Jamu traditional herbal medicine.
“Litsea cubeba has been employed in traditional Chinese medicine for centuries, where the dried fruits—called 'Bi Cheng Qie' or mountain pepper—were used to warm the stomach, relieve pain, and address digestive stagnation including vomiting, hiccups, and cold-type abdominal pain within the framework of qi-regulating therapies. In Indonesia, the plant is incorporated into Jamu, the archipelago's indigenous herbal medicine tradition, as an antimicrobial and digestive remedy, with preparations varying regionally across Java, Sumatra, and Kalimantan. The fruit's resemblance to Piper nigrum (black pepper) earned it the name 'cubeba,' referencing the similarly shaped cubeb pepper (Piper cubeba), and its intensely lemony aroma led to its Western common name 'May Chang,' popularized in the fragrance industry during the 20th century as a natural source of citral for perfumery and flavoring. The essential oil became commercially significant globally following expanded extraction operations in southern China from the mid-20th century onward, transitioning the plant from a regional traditional medicine ingredient to an internationally traded aromatic commodity.”Traditional Medicine
Scientific Research
The scientific evidence base for Litsea cubeba consists entirely of in vitro phytochemical and bioassay studies, with no published human clinical trials or controlled animal intervention studies identified as of the available literature. Research has employed gas chromatography-mass spectrometry (GC-MS) characterization of essential oil fractions across plant parts, followed by standard microbiological assays (MIC, MFC determinations), DPPH/ABTS antioxidant assays, and cancer cell line cytotoxicity panels—all well-established in vitro methodologies but insufficient to establish clinical efficacy or safety in humans. Quantified outcomes include MIC of 5.24 μg/mL against S. aureus, antifungal MIC/MFC of 125 μg/mL against F. verticillioides, DPPH IC50 of 872–1720.1 μg/mL across fractions, and inhibition of fumonisin synthesis at p < 0.01 significance, representing reproducible but preclinical data points. The evidence base, while internally consistent across multiple independent phytochemical analyses, cannot support therapeutic recommendations or dosing guidelines, and translation from in vitro to human physiological relevance has not been established.
Preparation & Dosage
Traditional preparation
**Essential Oil (Steam/Hydrodistillation)**
00 mg/mL and antifungal at 125 μg/mL
The primary commercial and research form; extracted from fruits, leaves, or bark via steam distillation or hydrodistillation; no standardized therapeutic dose established for human use; in vitro antibacterial concentrations tested at 2..
**Topical Application (Aromatherapy/Cosmetic)**
Typically diluted to 1–3% in carrier oils (e.g., jojoba, almond oil) for skin or aromatic use; undiluted essential oil may cause dermal or mucosal irritation due to high citral content.
**Traditional Jamu Preparation (Indonesia)**
Dried Litsea cubeba fruits are incorporated into multi-herb decoctions or ground into powders blended with other botanicals; no standardized fruit powder dose has been validated clinically.
**Food Preservative Application**
0 mg/mL to inhibit microbial contamination; these concentrations are not intended for direct therapeutic supplementation
In food science research, LCEO is applied at concentrations around 0.1–2..
**Standardization**
Commercial LCEO is often standardized to citral content (neral + geranial), typically 60–80% by GC analysis; standardization to specific citral percentages is used in flavor and fragrance industries but not yet applied to medicinal dosing protocols.
**Timing and Administration Notes**
No clinical timing recommendations exist; traditional use is generally with meals for digestive complaints; essential oil inhalation or diffusion is used in aromatic contexts without established dosing schedules.
Nutritional Profile
Litsea cubeba is not consumed as a food ingredient in meaningful quantities and therefore has no characterized macronutrient or micronutrient profile relevant to human nutrition. Its primary bioactive constituents are volatile essential oil compounds concentrated in the fruit pericarp and leaf glands: citral (neral + geranial combined, 45–80% of fruit oil), limonene (7–31% depending on fraction and origin), sabinene (up to 17.6% in branch oil), linalool (up to 9.5% in leaf oil), citronellal (~14%), and α-pinene (~6% in branch oil), with up to 36 total compounds identified by GC-MS, predominantly oxygenated monoterpenes. The oil yield from fruits via hydrodistillation is approximately 3–5% by weight, depending on fruit maturity and geographic origin. Bioavailability of these volatile terpenes through oral ingestion, inhalation, or dermal absorption has not been formally characterized for Litsea cubeba specifically; however, monoterpenes as a class are known to be lipophilic and capable of crossing biological membranes, with rapid absorption and hepatic metabolism expected.
How It Works
Mechanism of Action
The primary mechanism underlying LCEO's antimicrobial activity involves membrane disruption mediated by citral (the combined neral and geranial isomers), whose α,β-unsaturated aldehyde structure enables intercalation into phospholipid bilayers, increasing membrane permeability, dissipating proton motive force, and ultimately causing leakage of intracellular contents in both Gram-positive and Gram-negative bacteria. Antifungal action against Fusarium species proceeds via physical deformation of hyphal architecture and inhibition of spore germination, alongside interference with fumonisin biosynthetic gene pathways, evidenced by dose-dependent reductions in fumonisin B1 and B2 concentrations (p < 0.01) in in vitro culture assays. Antioxidant activity is attributable to the hydrogen-donating capacity of phenolic and terpenoid components including linalool and limonene, which quench DPPH and ABTS radicals through electron transfer and hydrogen atom transfer mechanisms. Putative cytotoxic effects on HT-29 and HeLa cell lines are hypothesized to involve terpene-driven lipid peroxidation of cancer cell membranes and non-specific oxidative stress induction, though specific intracellular targets such as caspase pathways or mitochondrial membrane potential disruption have not been characterized in published studies.
Clinical Evidence
No human clinical trials investigating Litsea cubeba or its essential oil for any health indication have been identified in the published literature; all available quantitative data derive from in vitro cell-based and microbiological experiments. The antimicrobial studies using MIC-based methodology provide standardized and reproducible preclinical endpoints (5.24 μg/mL antibacterial, 125 μg/mL antifungal), but effective in vivo concentrations cannot be extrapolated from these values without bioavailability, pharmacokinetic, and toxicological data in living systems. Traditional use in Indonesian Jamu for digestive complaints and Chinese ethnobotany for respiratory and gastrointestinal conditions represents decades of empirical human exposure but is not supported by formal outcome measurement or control conditions. The overall confidence in clinical efficacy for any specific indication is very low; the ingredient should be regarded as a promising candidate for applied food-safety and antimicrobial research rather than a clinically validated therapeutic agent.
Safety & Interactions
Litsea cubeba essential oil lacks comprehensive human toxicology data, and no maximum safe dose for oral, topical, or inhaled administration has been formally established through clinical studies; the available safety inferences are derived from its cytotoxic activity against HT-29 and HeLa cell lines in vitro, which indicates potential cellular toxicity at elevated concentrations that requires caution particularly with undiluted or high-dose applications. Topical application of undiluted LCEO poses risk of skin irritation, sensitization, and mucous membrane irritation due to the high citral content (60–80%), which is a recognized dermal sensitizer; dilution to 1–3% in carrier oils is the standard precautionary practice aligned with fragrance industry guidelines for citral-containing products. No specific drug interactions have been documented in published research; however, given that limonene and other monoterpenes are substrates and potential modulators of cytochrome P450 enzymes (particularly CYP1A2 and CYP3A4) based on research on structurally similar terpenes, theoretical interactions with medications metabolized by these pathways (including statins, benzodiazepines, and certain antibiotics) cannot be excluded. Pregnancy and lactation safety has not been studied; the significant cytotoxic activity observed in cell lines and the high concentration of bioactive aldehydes makes oral ingestion or high-dose topical use inadvisable during pregnancy until safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Litsea cubeba (Lour.) Pers.May ChangMountain PepperBi Cheng QieLCEOLemon Pepper Tree
Frequently Asked Questions
What is Litsea cubeba used for?
Litsea cubeba is used primarily for its essential oil (LCEO), which demonstrates antimicrobial, antifungal, and antioxidant properties in laboratory studies. Traditionally, it is incorporated into Indonesian Jamu preparations and Chinese herbal medicine for digestive complaints including bloating and stomach pain, and its high citral content (up to 80% in fruit oil) makes it valuable in the fragrance, flavor, and natural preservative industries.
Is Litsea cubeba the same as May Chang?
Yes, May Chang is the most widely recognized Western common name for Litsea cubeba, derived from its intensely lemony aroma and its prominence in the fragrance industry as a natural citral source. The plant is also called mountain pepper in reference to its small, pepper-like fruits, and 'Bi Cheng Qie' in traditional Chinese medicine contexts.
What are the main active compounds in Litsea cubeba essential oil?
The dominant bioactive compounds in Litsea cubeba essential oil are citral monoterpenes—specifically neral (Z-citral) and geranial (E-citral)—which together comprise 45–80% of fruit oil depending on extraction method and geographic origin. Additional significant constituents include limonene (7–31%), sabinene (up to 17.6%), linalool (up to 9.5%), citronellal (~14%), and α-pinene (~6%), with up to 36 total compounds identified by GC-MS analysis.
Are there clinical trials supporting Litsea cubeba health claims?
No human clinical trials for Litsea cubeba have been published to date; all available efficacy data come from in vitro laboratory studies using microbiological assays and cell culture models. While these studies produce reproducible and quantified outcomes—such as an antibacterial MIC of 5.24 μg/mL against Staphylococcus aureus—they cannot be directly translated into clinical recommendations without supporting pharmacokinetic, bioavailability, and human safety data.
Is Litsea cubeba essential oil safe to use on skin?
Litsea cubeba essential oil should not be applied undiluted to skin due to its very high citral content (60–80%), which is a recognized dermal sensitizer and irritant at elevated concentrations. Standard fragrance industry precautions recommend diluting LCEO to 1–3% in a carrier oil before topical application; individuals with sensitive skin or known citrus allergies should perform a patch test, and no safety data exists for use during pregnancy or lactation.
How does Litsea cubeba essential oil compare to other citral-rich oils for antimicrobial purposes?
Litsea cubeba essential oil contains high concentrations of citral (neral and geranial isomers), achieving antibacterial MIC values as low as 5.24 μg/mL against Staphylococcus aureus, comparable to or exceeding other citral-rich oils like lemongrass. Unlike some alternatives, LCEO also contains verbenol, which provides additional activity against Gram-negative bacteria such as E. coli, making it a broad-spectrum option. The combination of these compounds gives May Chang a more comprehensive antimicrobial profile than single-component essential oils.
Who should avoid using Litsea cubeba essential oil due to safety concerns?
Pregnant and nursing women should avoid internal use of Litsea cubeba essential oil due to limited safety data during these periods. Individuals with sensitive skin or citral allergies should perform patch testing before topical application, as the high citral content may cause irritation or photosensitivity in susceptible individuals. Children under 12 and those with liver conditions should consult a healthcare provider before use, as essential oil safety profiles vary significantly by age and health status.
What is the difference between using Litsea cubeba essential oil versus the dried herb or extract form?
Litsea cubeba essential oil is the most concentrated form, containing volatile compounds like citral and verbenol at therapeutic levels, making it effective at lower doses (typically 1-3 drops diluted). The dried herb or aqueous extracts contain lower concentrations of active compounds and are gentler for internal consumption but may require larger quantities to achieve antimicrobial or antifungal effects. Essential oil is preferred for rapid antimicrobial action, while dried forms are better suited for culinary use and individuals requiring mild, sustained benefits with less intensity.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w litsea-cubeba-may-chang curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
